Skip to main content
Erschienen in: Cancer Causes & Control 3/2007

01.04.2007 | Original Paper

Ambient UV, personal sun exposure and risk of multiple primary melanomas

verfasst von: Anne Kricker, Bruce K. Armstrong, Chris Goumas, Melisa Litchfield, Colin B. Begg, Amanda J. Hummer, Loraine D. Marrett, Beth Theis, Robert C. Millikan, Nancy Thomas, Hoda Anton Culver, Richard P. Gallagher, Terence Dwyer, Timothy R. Rebbeck, Peter A. Kanetsky, Klaus Busam, Lynn From, Urvi Mujumdar, Roberto Zanetti, Marianne Berwick, for the GEM Study Group

Erschienen in: Cancer Causes & Control | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

Sun exposure is the main cause of melanoma in populations of European origin. No previous study has examined the effect of sun exposure on risk of multiple primary melanomas compared with people who have one melanoma.

Methods

We identified and enrolled 2,023 people with a first primary melanoma (controls) and 1,125 with multiple primary melanomas (cases) in seven centers in four countries, recorded their residential history to assign ambient UV and interviewed them about their sun exposure.

Results

Risk of multiple primary melanomas increased significantly (P < 0.05) to OR = 2.10 for the highest exposure quarter of ambient UV irradiance at birth and 10 years of age, to OR = 1.38 for lifetime recreational sun exposure, to OR = 1.85 for beach and waterside activities, to OR = 1.57 for vacations in a sunnier climate, to OR = 1.50 for sunburns. Occupational sun exposure did not increase risk (OR = 1.03 for highest exposure). Recreational exposure at any age increased risk and appeared to add to risk from ambient UV in early life.

Conclusions

People who have had a melanoma can expect to reduce their risk of a further melanoma by reducing recreational sun exposure whatever their age. The same is probably true for a person who has never had a melanoma.
Literatur
1.
Zurück zum Zitat Levi F, Randimbison L, Te VC, La Vecchia C (2005) High constant incidence rates of second cutaneous melanomas. Int J Cancer 117:877–879PubMedCrossRef Levi F, Randimbison L, Te VC, La Vecchia C (2005) High constant incidence rates of second cutaneous melanomas. Int J Cancer 117:877–879PubMedCrossRef
2.
Zurück zum Zitat Blackwood MA, Holmes R, Synnestvedt M et al (2002) Multiple primary melanoma revisited. Cancer 94:2248–2255PubMedCrossRef Blackwood MA, Holmes R, Synnestvedt M et al (2002) Multiple primary melanoma revisited. Cancer 94:2248–2255PubMedCrossRef
3.
Zurück zum Zitat Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W (2001) Multiple primary melanomas. J Am Acad Dermatol 44:22–27PubMedCrossRef Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W (2001) Multiple primary melanomas. J Am Acad Dermatol 44:22–27PubMedCrossRef
4.
Zurück zum Zitat Ferrone CR, Ben Porat L, Panageas KS et al (2005) Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 294:1647–1654PubMedCrossRef Ferrone CR, Ben Porat L, Panageas KS et al (2005) Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 294:1647–1654PubMedCrossRef
5.
Zurück zum Zitat International Agency for Research on Cancer (1992). Solar and ultraviolet radiation, vol 55. IARC Monographs on the evaluation of carcinogenic risks to humans. IARC, Lyon International Agency for Research on Cancer (1992). Solar and ultraviolet radiation, vol 55. IARC Monographs on the evaluation of carcinogenic risks to humans. IARC, Lyon
6.
Zurück zum Zitat Begg CB, Hummer AJ, Mujumdar U et al (2006) A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 35:756–764PubMedCrossRef Begg CB, Hummer AJ, Mujumdar U et al (2006) A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 35:756–764PubMedCrossRef
7.
Zurück zum Zitat Kricker A, Vajdic CM, Armstrong BK (2005) Reliability and validity of a telephone questionnaire for estimating lifetime personal sun exposure in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 14:2427–2432PubMedCrossRef Kricker A, Vajdic CM, Armstrong BK (2005) Reliability and validity of a telephone questionnaire for estimating lifetime personal sun exposure in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 14:2427–2432PubMedCrossRef
8.
Zurück zum Zitat Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3:452–456PubMed Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3:452–456PubMed
9.
Zurück zum Zitat Begg CB, Gray R (1987) Methodology for case-control studies with prevalent cases. Biometrika 74:191–195CrossRef Begg CB, Gray R (1987) Methodology for case-control studies with prevalent cases. Biometrika 74:191–195CrossRef
10.
Zurück zum Zitat Solomon CC, White E, Kristal AR, Vaughan T (2004) Melanoma and lifetime UV radiation. Cancer Causes Control 15:893–902PubMedCrossRef Solomon CC, White E, Kristal AR, Vaughan T (2004) Melanoma and lifetime UV radiation. Cancer Causes Control 15:893–902PubMedCrossRef
11.
Zurück zum Zitat Gruber SB, Armstrong BK (2006) Cutaneous and ocular melanoma. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. OUP, New York pp 1196–1229 Gruber SB, Armstrong BK (2006) Cutaneous and ocular melanoma. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. OUP, New York pp 1196–1229
12.
Zurück zum Zitat Holman CD, Armstrong BK (1984) Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 73:75–82PubMed Holman CD, Armstrong BK (1984) Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 73:75–82PubMed
13.
Zurück zum Zitat Parkin DM, Steinitz R, Khlat M, Kaldor J, Katz L, Young J (1990) Cancer in Jewish migrants to Israel. Int J Cancer 45:614–621PubMedCrossRef Parkin DM, Steinitz R, Khlat M, Kaldor J, Katz L, Young J (1990) Cancer in Jewish migrants to Israel. Int J Cancer 45:614–621PubMedCrossRef
14.
Zurück zum Zitat Armstrong BK (2004) How does sun exposure cause skin cancer—epidemiological perspective. In: Hill D, English DR, Elwood JM (eds) Prevention of skin cancer, cancer causes—cancer prevention. Kluwer Academic Publishers, New York, pp 89–116 Armstrong BK (2004) How does sun exposure cause skin cancer—epidemiological perspective. In: Hill D, English DR, Elwood JM (eds) Prevention of skin cancer, cancer causes—cancer prevention. Kluwer Academic Publishers, New York, pp 89–116
15.
Zurück zum Zitat Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma. II. Sun exposure. Eur J Cancer 41:45–60PubMedCrossRef Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma. II. Sun exposure. Eur J Cancer 41:45–60PubMedCrossRef
16.
Zurück zum Zitat Whiteman DC, Whiteman CA, Green AC (2001) Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12:69–82PubMedCrossRef Whiteman DC, Whiteman CA, Green AC (2001) Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12:69–82PubMedCrossRef
17.
Zurück zum Zitat Goggins WB, Tsao H (2003) A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 97:639–643PubMedCrossRef Goggins WB, Tsao H (2003) A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 97:639–643PubMedCrossRef
18.
Zurück zum Zitat Begg CB, Berwick M (1997) A note on the estimation of relative risks of rare genetic susceptibility markers. Cancer Epidemiol Biomarkers Prev 6:99–103PubMed Begg CB, Berwick M (1997) A note on the estimation of relative risks of rare genetic susceptibility markers. Cancer Epidemiol Biomarkers Prev 6:99–103PubMed
19.
Zurück zum Zitat Autier P, Dore JF (1998) Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. Int J Cancer 77:533–537PubMedCrossRef Autier P, Dore JF (1998) Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. Int J Cancer 77:533–537PubMedCrossRef
Metadaten
Titel
Ambient UV, personal sun exposure and risk of multiple primary melanomas
verfasst von
Anne Kricker
Bruce K. Armstrong
Chris Goumas
Melisa Litchfield
Colin B. Begg
Amanda J. Hummer
Loraine D. Marrett
Beth Theis
Robert C. Millikan
Nancy Thomas
Hoda Anton Culver
Richard P. Gallagher
Terence Dwyer
Timothy R. Rebbeck
Peter A. Kanetsky
Klaus Busam
Lynn From
Urvi Mujumdar
Roberto Zanetti
Marianne Berwick
for the GEM Study Group
Publikationsdatum
01.04.2007
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 3/2007
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0091-x

Weitere Artikel der Ausgabe 3/2007

Cancer Causes & Control 3/2007 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.